Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis Inc. has demonstrated robust financial performance, reporting a revenue of $8.8 million in the second quarter, reflecting a remarkable year-over-year increase of 95% and an 18% sequential growth. The company is on track to achieve continued revenue growth across its various streams, with projections indicating an increase to $43 million in total revenue by FY26, fueled by rising system sales and catheter utilization. Additionally, regulatory advancements for new products, such as the MAGiC ablation catheter and the MAGiC Sweep mapping catheter, position Stereotaxis to leverage its innovative portfolio and drive further expansion in the robotic interventional market.

Bears say

Stereotaxis Inc has reported operating expenses of $8.6 million, with adjusted expenses decreasing to $6.0 million from $6.8 million in the previous year, indicating a decline but still reflecting high operational costs. Notable concerns affecting the company’s outlook include delays in product approvals, ongoing supply issues, changes in reimbursement rates, and competitive pressures from both manual and robotic systems, all of which could significantly impact revenue expectations. Additionally, with a net loss of $3.8 million and a limited cash runway of two years, Stereotaxis may need to secure further financing to maintain its operations and sales expansion, raising further uncertainties about its financial stability.

Stereotaxis Inc (STXS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 2 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.